Hindustan Unilever logo

Hindustan Unilever CEO, MD, chairman, board of directors and AGM

NSE: HINDUNILVRBSE: 500696Diversified FMCGLarge Cap

Formerly Hindustan Lever
Last close ₹1,814.70down ₹13.60 (0.74%)BSE ₹1,820.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,828.30.

52-week range of traded prices to 23 Oct 2026
₹1,781.10Low, 23 Oct 2026₹2,667.20High, 23 Oct 2025
Market cap
₹4,26,380 Cr10th largest listed
P/E
28.5
P/E without one-offs
39.8
P/B
8.7
Dividend yield
2.24%
ROE
30.5%
ROE without one-offs
21.8%
ROCE
28.4%
Debt to equity
0.00
Volume, NSE
11,92,73253.4% delivered

Hindustan Unilever board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonNitin Paranjpe
  • Managing director and CEOPriya Sukumar Nair
  • Company Secretary and Compliance OfficerRadhika Kartik Shah

9 directors5 independent3 executive1 non-executive

  • Nitin Paranjpe · ChairpersonNon-executive · joined Mar 2022 · reappointed Mar 2022 · 2 listed boards · 1 as independent · 1 committee seat
  • Priya Sukumar Nair · Managing director and CEOExecutive · joined Aug 2025 · reappointed Aug 2025 · 1 listed board · 1 committee seat
  • Niranjan Kumar GuptaExecutive · joined Nov 2025 · reappointed Nov 2025 · 2 listed boards · 1 as independent · 2 committee seats
  • Biddappa Ponnappa BittiandaExecutive · joined Jun 2024 · reappointed Jun 2024 · 1 listed board
  • Ashu SuyashIndependent · joined Nov 2021 · reappointed Nov 2021 · 55 months as independent · 3 listed boards · 3 as independent · 3 committee seats, 2 as chair
  • Ranjay Satya GulatiIndependent · joined Apr 2023 · reappointed Apr 2023 · 39 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Neelam DhawanIndependent · joined Aug 2023 · reappointed Aug 2023 · 35 months as independent · 6 listed boards · 6 as independent · 6 committee seats, 3 as chair
  • Tarun BajajIndependent · joined Dec 2023 · reappointed Dec 2023 · 31 months as independent · 4 listed boards · 4 as independent · 5 committee seats, 1 as chair
  • Bobby Kanubhai ParikhIndependent · joined Dec 2025 · reappointed Dec 2025 · 7 months as independent · 4 listed boards · 3 as independent · 7 committee seats, 3 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

4 directors who left
  • Ritesh Ramkrishna Tiwari, left 1 Nov 2025: Others
  • Rohit Jawa, left 1 Aug 2025: Others
  • Devopam Bajpai, left 1 Jan 2025: Others
  • Kalpana Jaisingh Morparia, left 9 Oct 2024: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 30 Apr 20269 of 9 present5 independent · 1 day in between
    • 28 Apr 20269 of 9 present5 independent · 69 days in between
    • 17 Feb 20269 of 9 present5 independent · 4 days in between
    • 12 Feb 20269 of 9 present5 independent

  • Audit Committee

    Chair Ashu Suyash

    Neelam Dhawan, Tarun Bajaj, Bobby Kanubhai Parikh

    • 29 Apr 20264 of 4 present4 independent · 35 days in between
    • 24 Mar 20264 of 4 present4 independent · 40 days in between
    • 11 Feb 20263 of 4 present3 independent

  • Nomination and remuneration committee

    Chair Neelam Dhawan

    Ashu Suyash, Ranjay Satya Gulati, Tarun Bajaj

    • 28 Apr 20264 of 4 present4 independent · 67 days in between
    • 19 Feb 20264 of 4 present4 independent

  • Stakeholders Relationship Committee

    Chair Ranjay Satya Gulati

    Tarun Bajaj, Priya Sukumar Nair

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Bobby Kanubhai Parikh

    Neelam Dhawan, Ashu Suyash, Tarun Bajaj, Priya Sukumar Nair

    • 27 Apr 20265 of 5 present4 independent

  • Corporate Social Responsibility Committee

    Chair Tarun Bajaj

    Neelam Dhawan, Ranjay Satya Gulati

    • 27 Apr 20263 of 3 present3 independent · 33 days in between
    • 24 Mar 20263 of 3 present3 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s. Walker Chandiok & Co. LLPPeer-review certificate valid to May 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Hindustan Unilever AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Hindustan Unilever dividend history

Annual general meeting, 30 Jun 2026

11,60,840 shareholders on the register on 23 Jun 2026; present: 7 promoters and 137 others; votes counted by S. N. Ananthasubramanian / S. N. Ananthasubramanian & Co..The company's voting result (opens in a new tab)

  1. Adoption of audited financial statements (including audited consolidated financial statements) for the Financial Year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.43%

    Turnout: all 85.00% · promoters 100.00% · institutions 86.96% · other public 0.50%

  2. Confirmation of Interim Dividend and declaration of Final Dividend for the Financial Year ended 31st March, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.10%

    Turnout: all 85.31% · promoters 100.00% · institutions 88.12% · other public 0.50%

  3. Re-appointment of Mr. Nitin Paranjpe (DIN: 00045204) as a Director
    Ordinary
    99.63% for0.37% against

    Against: promoters 0.00% · institutions 1.34% · other public 3.03%

    Turnout: all 85.30% · promoters 100.00% · institutions 88.09% · other public 0.50%

  4. Re-appointment of Mr. Niranjan Gupta (DIN: 07806792) as a Director
    Ordinary
    99.91% for0.09% against

    Against: promoters 0.00% · institutions 0.31% · other public 3.42%

    Turnout: all 85.30% · promoters 100.00% · institutions 88.10% · other public 0.50%

  5. Re-appointment of Mr. B. P. Biddappa (DIN: 06586886) as a Director
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.30% · other public 3.86%

    Turnout: all 85.30% · promoters 100.00% · institutions 88.10% · other public 0.50%

  6. Re-appointment of Ms. Ashu Suyash (DIN: 00494515) as an Independent Director of the Company
    Special
    99.66% for0.34% against

    Against: promoters 0.00% · institutions 1.24% · other public 5.66%

    Turnout: all 85.30% · promoters 100.00% · institutions 88.10% · other public 0.49%

  7. Ratification of remuneration to Cost Auditors for Financial Year ending 31st March, 2027
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.65%

    Turnout: all 85.30% · promoters 100.00% · institutions 88.10% · other public 0.50%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 6 Jan 2026, 2 resolutions

11,42,011 shareholders on the register on 28 Nov 2025; votes counted by S. N. Viswanathan / S. N. Ananthasubramanian & Co..The company's voting result (opens in a new tab)

  1. Appointment of Mr. Niranjan Gupta (DIN: 07806792) as the Whole-time Director of the Company, liable to retire by rotation, to hold office for a period of 5 (five) consecutive years i.e., from 1st November, 2025 to 31st October, 2030MoreLess
    Ordinary
    99.56% for0.44% against

    Against: promoters 0.00% · institutions 1.66% · other public 0.26%

    Turnout: all 85.38% · promoters 100.00% · institutions 88.13% · other public 6.45%

  2. Appointment of Mr. Bobby Parikh (DIN: 00019437) as an Independent Director of the Company, not liable to retire by rotation, to hold office for a period of 5 (five) consecutive years i.e. from 1st December, 2025 to 30th November, 2030MoreLess
    Special
    99.59% for0.41% against

    Against: promoters 0.00% · institutions 1.54% · other public 0.59%

    Turnout: all 85.38% · promoters 100.00% · institutions 88.13% · other public 6.45%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Sep 2025, 1 resolution

11,48,495 shareholders on the register on 22 Aug 2025; votes counted by S. N. Ananthasubramanian / S. N. Ananthasubramanian & Co..The company's voting result (opens in a new tab)

  1. Appointment of Ms. Priya Nair (DIN: 07119070) as the Managing Director & Chief Executive Officer of the Company
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.42% · other public 2.13%

    Turnout: all 85.56% · promoters 100.00% · institutions 89.08% · other public 0.76%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Meeting called by the tribunal, 12 Aug 2025, 1 resolution

11,64,814 shareholders on the register on 5 Aug 2025; present: 7 promoters and 136 others; votes counted by Ashwini Gupta / A R Gupta & Co..The company's voting result (opens in a new tab)

  1. To consider and approve the Scheme of Arrangement between Hindustan Unilever Limited, Kwality Wall’s (India) Limited and their respective shareholders
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.03%

    Turnout: all 85.36% · promoters 100.00% · institutions 88.47% · other public 0.75%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jun 2025, 7 resolutions

12,10,142 shareholders on the register on 23 Jun 2025; present: 7 promoters and 175 others; votes counted by S. N. Ananthasubramanian / S. N. Ananthasubramanian & Co..The company's voting result (opens in a new tab)

  1. Adoption of Audited Financial Statements (including audited consolidated financial statements) together with the Reports of Board of Directors and Auditors thereon, for the Financial Year ended 31st March, 2025MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.16%

    Turnout: all 85.08% · promoters 100.00% · institutions 87.97% · other public 0.57%

  2. Confirmation of Interim Dividend and declaration of Final Dividend for the Financial Year ended 31st March, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.39%

    Turnout: all 85.42% · promoters 100.00% · institutions 89.27% · other public 0.57%

  3. Re-appointment of Mr. Nitin Paranjpe (DIN: 00045204) as a Director
    Ordinary
    99.55% for0.45% against

    Against: promoters 0.00% · institutions 1.63% · other public 1.98%

    Turnout: all 85.39% · promoters 100.00% · institutions 89.14% · other public 0.56%

  4. Re-appointment of Mr. Ritesh Tiwari (DIN: 05349994) as a Director
    Ordinary
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.41% · other public 2.64%

    Turnout: all 85.42% · promoters 100.00% · institutions 89.27% · other public 0.56%

  5. Re-appointment of Mr. Biddappa Ponnappa Bittianda (DIN: 06586886) as a Director
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.43% · other public 2.72%

    Turnout: all 85.42% · promoters 100.00% · institutions 89.26% · other public 0.56%

  6. Appointment of M/s. Parikh & Associates, Company Secretaries (ICSI Unique Code: P1988MH009800) as Secretarial Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.80%

    Turnout: all 85.42% · promoters 100.00% · institutions 89.26% · other public 0.56%

  7. Ratification of remuneration to Cost Auditors for financial year ending 31st March, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.02%

    Turnout: all 85.41% · promoters 100.00% · institutions 89.23% · other public 0.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 21 Jun 2024, 11 resolutions

Present: 7 promoters and 192 others.The company's voting result (opens in a new tab)

  1. Adoption of Audited Financial Statements together with the Report of Board of Directors and Auditors’ thereon for the Financial Year ended 31st March, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.88%

    Turnout: all 83.42% · promoters 100.00% · institutions 82.46% · other public 0.48%

  2. Confirmation of the Interim Dividend and declaration of Final Dividend for Financial Year ended 31st March, 2024.
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 0.54% · other public 0.40%

    Turnout: all 83.88% · promoters 100.00% · institutions 84.23% · other public 0.48%

  3. To appoint a Director in place of Mr. Nitin Paranjpe (DIN:00045204), who retires by rotation and being eligible, offers his candidature for re-appointment
    Ordinary
    98.84% for1.16% against

    Against: promoters 0.00% · institutions 4.46% · other public 1.89%

    Turnout: all 83.76% · promoters 100.00% · institutions 83.75% · other public 0.48%

  4. To appoint a Director in place of Mr. Dev Bajpai (DIN:00050516), who retires by rotation and being eligible, offers his candidature for re-appointment.
    Ordinary
    99.79% for0.21% against

    Against: promoters 0.00% · institutions 0.81% · other public 2.30%

    Turnout: all 83.88% · promoters 100.00% · institutions 84.23% · other public 0.48%

  5. To appoint a Director in place of Mr. Ritesh Tiwari (DIN:05349994), who retires by rotation and being eligible, offers his candidature for re-appointment
    Ordinary
    99.79% for0.21% against

    Against: promoters 0.00% · institutions 0.79% · other public 2.98%

    Turnout: all 83.88% · promoters 100.00% · institutions 84.23% · other public 0.48%

  6. Appointment of M/s. Walker Chandiok & Co. LLP, Chartered Accountants (Firm Registration No. 001076N/N500013), as the Statutory Auditors of the Company.
    Ordinary
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.10% · other public 0.98%

    Turnout: all 83.88% · promoters 100.00% · institutions 84.23% · other public 0.48%

  7. Approval of Material Related Party Transaction
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.31%

    Turnout: all 21.91% · promoters 0.00% · institutions 83.98% · other public 0.45%

  8. Appointment of Mr. B.P. Biddappa (DIN: 06586886) as a Whole-time Director of the Company
    Ordinary
    99.43% for0.57% against

    Against: promoters 0.00% · institutions 2.16% · other public 2.19%

    Turnout: all 83.88% · promoters 100.00% · institutions 84.23% · other public 0.48%

  9. Revision in remuneration payable to Non-Executive Directors by way of commission
    Ordinary
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 0.15% · other public 5.51%

    Turnout: all 83.88% · promoters 100.00% · institutions 84.23% · other public 0.48%

  10. Ratification of remuneration to Cost Auditors for the financial year ended 31st March, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.64%

    Turnout: all 83.87% · promoters 100.00% · institutions 84.18% · other public 0.48%

  11. Ratification of remuneration to Cost Auditors for the financial year ending 31st March, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.72%

    Turnout: all 83.87% · promoters 100.00% · institutions 84.18% · other public 0.48%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 5 Mar 2024, 2 resolutions

The company's voting result (opens in a new tab)

  1. Introduction and Implementation of ‘Hindustan Unilever Limited Performance Share Plan Scheme 2024’
    Special
    83.89% for16.11% against

    Against: promoters 0.00% · institutions 61.66% · other public 5.40%

    Turnout: all 83.89% · promoters 100.00% · institutions 84.27% · other public 0.59%

  2. Extension of ‘Hindustan Unilever Limited Performance Share Plan Scheme 2024’ to Employees of Subsidiary Company (ies) of the Company.
    Special
    83.84% for16.16% against

    Against: promoters 0.00% · institutions 61.94% · other public 5.62%

    Turnout: all 83.83% · promoters 100.00% · institutions 84.04% · other public 0.59%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 Jan 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Tarun Bajaj (DIN: 02026219) as an Independent Director of the Company
    Special
    99.90% for0.10% against

    Against: promoters 0.00% · institutions 0.38% · other public 3.32%

    Turnout: all 84.31% · promoters 100.00% · institutions 86.07% · other public 0.45%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 30 Jun 2026, 43 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of audited financial statements (including audited consolidated financial statements) for the Financial Year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereonMoreLess
    42 for0 against
  • Confirmation of Interim Dividend and declaration of Final Dividend for the Financial Year ended 31st March, 2026
    42 for0 against
  • Re-appointment of Mr. Nitin Paranjpe (DIN: 00045204) as a Director
    43 for0 against
  • Re-appointment of Mr. Niranjan Gupta (DIN: 07806792) as a Director
    42 for0 against
  • Re-appointment of Mr. B. P. Biddappa (DIN: 06586886) as a Director
    43 for0 against
  • Re-appointment of Ms. Ashu Suyash (DIN: 00494515) as an Independent Director of the Company
    43 for0 against
  • Ratification of remuneration to Cost Auditors for Financial Year ending 31st March, 2027
    34 for0 against
6 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • 7) Ratify remuneration of Rs 1.7 mn payable to R Nanabhoy & Co. as cost auditors for FY27.
    1 for0 against
  • Ratify remuneration of Rs 1.7 mn payable to R Nanabhoy & Co. as cost auditors for FY27
    7 for0 against

Mutual fund votes, meeting of 6 Jan 2026, 38 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Appointment of Mr. Niranjan Gupta (DIN: 07806792) as the Whole-time Director of the Company, liable to retire by rotation, to hold office for a period of 5 (five) consecutive years i.e., from 1st November, 2025 to 31st October, 2030MoreLess
    37 for0 against
  • Appointment of Mr. Bobby Parikh (DIN: 00019437) as an Independent Director of the Company, not liable to retire by rotation, to hold office for a period of 5 (five) consecutive years i.e. from 1st December, 2025 to 30th November, 2030MoreLess
    37 for0 against
2 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
6 earlier meetings

Mutual fund votes, meeting of 27 Sep 2025, 39 fund houses

  • Appointment of Ms. Priya Nair (DIN: 07119070) as the Managing Director & Chief Executive Officer of the Company
    39 for0 against

Mutual fund votes, meeting of 12 Aug 2025, 37 fund houses

  • To consider and approve the Scheme of Arrangement between Hindustan Unilever Limited, Kwality Wall’s (India) Limited and their respective shareholders
    37 for0 against

Mutual fund votes, meeting of 30 Jun 2025, 38 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of Audited Financial Statements (including audited consolidated financial statements) together with the Reports of Board of Directors and Auditors thereon, for the Financial Year ended 31st March, 2025MoreLess
    37 for0 against
  • Confirmation of Interim Dividend and declaration of Final Dividend for the Financial Year ended 31st March, 2025
    37 for0 against
  • Re-appointment of Mr. Nitin Paranjpe (DIN: 00045204) as a Director
    38 for0 against
  • Re-appointment of Mr. Ritesh Tiwari (DIN: 05349994) as a Director
    38 for0 against
  • Re-appointment of Mr. Biddappa Ponnappa Bittianda (DIN: 06586886) as a Director
    38 for0 against
  • Appointment of M/s. Parikh & Associates, Company Secretaries (ICSI Unique Code: P1988MH009800) as Secretarial Auditors of the Company
    37 for0 against
  • Ratification of remuneration to Cost Auditors for financial year ending 31st March, 2026
    37 for0 against
4 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 21 Jun 2024, 35 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of Audited Financial Statements together with the Report of Board of Directors and Auditors’ thereon for the Financial Year ended 31st March, 2024
    33 for0 against
  • Confirmation of the Interim Dividend and declaration of Final Dividend for Financial Year ended 31st March, 2024.
    33 for0 against
  • To appoint a Director in place of Mr. Nitin Paranjpe (DIN:00045204), who retires by rotation and being eligible, offers his candidature for re-appointment
    33 for0 against
  • To appoint a Director in place of Mr. Dev Bajpai (DIN:00050516), who retires by rotation and being eligible, offers his candidature for re-appointment.
    33 for0 against
  • To appoint a Director in place of Mr. Ritesh Tiwari (DIN:05349994), who retires by rotation and being eligible, offers his candidature for re-appointment
    33 for0 against
  • Appointment of M/s. Walker Chandiok & Co. LLP, Chartered Accountants (Firm Registration No. 001076N/N500013), as the Statutory Auditors of the Company.
    33 for0 against
  • Approval of Material Related Party Transaction
    33 for0 against
  • Appointment of Mr. B.P. Biddappa (DIN: 06586886) as a Whole-time Director of the Company
    33 for0 against
  • Revision in remuneration payable to Non-Executive Directors by way of commission
    33 for0 against
  • Ratification of remuneration to Cost Auditors for the financial year ended 31st March, 2024
    31 for0 against
  • Ratification of remuneration to Cost Auditors for the financial year ending 31st March, 2025
    31 for0 against
14 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against
  • Item 9, as a fund house numbered it
    1 for0 against
  • Item 10, as a fund house numbered it
    1 for0 against
  • Item 11, as a fund house numbered it
    1 for0 against
  • 1.Adoption of Financial Statements together with the Report of Board of Directors and Auditors thereon for the Financial Year ended 31st March,2024. 2. Confirmation of interim dividend and declaration of final dividend. 3. Re-appointment of Mr. Nitin Paranjpe as a Director. 4. Re-appointment of Mr. Dev Bajpai as a Director 5. Re-appointment of Mr. Ritesh Tiwari as a Director. 6. Appointment of M/s. Walker Chandiok & Co. LLP,Chartered Accountants as the Statutory Auditors of the Company. 7. Approval for Material Related Party Transaction. 8. Appointment of Mr. Biddappa Bittianda Ponnappa as a Whole-time Director of the Company. 9. Revision in remuneration payable to Non-Executive Directors by way of Commission. 10. Ratification of remuneration to Cost Auditors for the Financial Year ended 31st March, 2024. 11. Ratification of remuneration to Cost Auditors for the Financial Year ending 31st March, 2025.MoreLess
    1 for0 against
  • Ratification of remuneration of Rs 1.4 mn payable to Nanabhoy & Co. as cost auditors for FY24
    2 for0 against
  • Ratification of remuneration of Rs 1.5 mn payable to Nanabhoy & Co. as cost auditors for FY25
    2 for0 against

Mutual fund votes, meeting of 5 Mar 2024, 31 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Introduction and Implementation of ‘Hindustan Unilever Limited Performance Share Plan Scheme 2024’
    Against 360 One Mutual Fund, Axis Mutual Fund, Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, DSP Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, NJ Mutual Fund, PGIM India Mutual Fund, PPFAS Mutual Fund, Quantum Mutual Fund, Sundaram Mutual Fund, Zerodha Mutual Fund
    • 360 One Mutual Fund, Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-compliant with SEBI (SBEB & SE) Regulations, 2021: In adequate Disclosure of exercise price/Pricing Formula.
    • Axis Mutual Fund, Bank of India Mutual Fund, DSP Mutual Fund, Sundaram Mutual FundUnder the scheme, the company proposes to grant upto 2.0 mn options to eligible employees (dilution of ~0.08% on the expandable capital base). The exercise price will be the face value of shares or such higher value as determined by the NRC. The vesting may be time based and/or performance based and the NRC may prescribe performance criteria for vesting such as market capitalization, revenue, EBITDA, return on capital employed, underlying sales growth, free-cash flow, underlying operating profit, market share etc.We recognize that the company is migrating from payment of 100% share-based compensation from the parent entity to 62% of the share-based compensation from the parent entity and 38% from Hindustan Unilever, which is a good practice. However, it is unclear whether all the options will vest based on satisfaction of performance criteria. We generally do not favour ESOP schemes where options are granted at a discount of more than 20% to the market price, unless the options have performance based vesting conditions which have clearly been disclosed. ESOPs are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the ESOPs are issued at significant discount to the market price. If the stock options are granted at a significant discount, there is no alignment between the interests of investors and those of employees.
    • HDFC Mutual FundESOPs are being granted at a discount to market price
    • HSBC Mutual FundA vote AGAINST these resolutions is warranted because: • There is no disclosure on the performance targets and threshold for vesting at different levels of performance. • The rationale for only a partial substitution of the long-term incentive scheme with the proposed scheme is unclear.
    • Invesco Mutual FundUnder the scheme, the company proposes to grant upto 2.0 mn options to eligible employees (dilution of ~0.08% on the expandable capital base). The exercise price will be the face value of shares or such higher value as determined by the NRC. The vesting may be time based and/or performance based and the NRC may prescribe performance criteria for vesting such as market capitalization, revenue, EBITDA, return on capital employed, underlying sales growth, free-cash flow, underlying operating profit, market share etc. We recognize that the company is migrating from payment of 100% share-based compensation from the parent entity to 62% of the share-based compensation from the parent entity and 38% from Hindustan Unilever, which is a good practice. However, it is unclear whether all the options will vest based on satisfaction of performance criteria. We generally do not favour ESOP schemes where options are granted at a discount of more than 20% to the market price, unless the options have performance based vesting conditions which have clearly been disclosed. ESOPs are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the ESOPs are issued at significant discount to the market price. If the stock options are granted at a significant discount, there is no alignment between the interests of investors and those of employees
    • Kotak Mahindra Mutual FundWhile company has provided details regarding quantum, vesting and impact on remuneration, they clarified that ESOP s are being issued at face value of Rs 1. As a policy, we don t encourage ESOP s to be issued at face value and hence voting against the resolution.
    • Nippon India Mutual FundStock options granted at steep discount
    • NJ Mutual FundInadequate disclosure regarding exercise price.
    • PPFAS Mutual FundInadequate disclosure regarding exercise price
    • Quantum Mutual FundCompany has issued the ESOPs at very discounted price. We do not support for such a discounted ESOPs.
    11 for19 against
  • Extension of ‘Hindustan Unilever Limited Performance Share Plan Scheme 2024’ to Employees of Subsidiary Company (ies) of the Company.
    Against 360 One Mutual Fund, Axis Mutual Fund, Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, DSP Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, NJ Mutual Fund, PGIM India Mutual Fund, PPFAS Mutual Fund, Quantum Mutual Fund, Sundaram Mutual Fund, Zerodha Mutual Fund
    • 360 One Mutual Fund, Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-compliant with SEBI (SBEB & SE) Regulations, 2021: In adequate Disclosure of exercise price/Pricing Formula.
    • Axis Mutual Fund, Bank of India Mutual Fund, DSP Mutual Fund, Invesco Mutual Fund, Sundaram Mutual FundThrough a separate resolution, the company proposed to extend the PSP 2024 scheme to employees of group companies including subsidiary and/or associate companies. Our view is linked to resolution #1.
    • HDFC Mutual FundESOPs are being granted at a discount to market price
    • HSBC Mutual FundA vote AGAINST these resolutions is warranted because: • There is no disclosure on the performance targets and threshold for vesting at different levels of performance. • The rationale for only a partial substitution of the long-term incentive scheme with the proposed scheme is unclear.
    • Kotak Mahindra Mutual FundWhile company has provided details regarding quantum, vesting and impact on remuneration, they clarified that ESOP s are being issued at face value of Rs 1. As a policy, we don t encourage ESOP s to be issued at face value and hence voting against the resolution.
    • Nippon India Mutual FundStock options granted at steep discount
    • NJ Mutual FundLinked to resolution #1
    • PPFAS Mutual FundInadequate disclosure regarding exercise price
    • Quantum Mutual FundCompany has issued the ESOPs at very discounted price. We do not support for such a discounted ESOPs.
    11 for19 against
2 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    Against Taurus Mutual Fund
    • Taurus Mutual FundThrough a separate resolution, the company proposed to extend the PSP 2024 scheme to employees of group companies including subsidiary and/or associate companies. Our view is linked to resolution #1.
    0 for1 against
  • Item 2, as a fund house numbered it
    Against Taurus Mutual Fund
    • Taurus Mutual FundUnder the scheme, the company proposes to grant upto 2.0 mn options to eligible employees (dilution of ~0.08% on the expandable capital base). The exercise price will be the face value of shares or such higher value as determined by the NRC. The vesting may be time based and/or performance based and the NRC may prescribe performance criteria for vesting such as market capitalization, revenue, EBITDA, return on capital employed, underlying sales growth, free-cash flow, underlying operating profit, market share etc.We recognize that the company is migrating from payment of 100% share-based compensation from the parent entity to 62% of the share-based compensation from the parent entity and 38% from Hindustan Unilever, which is a good practice. However, it is unclear whether all the options will vest based on satisfaction of performance criteria. We generally do not favour ESOP schemes where options are granted at a discount of more than 20% to the market price, unless the options have performance based vesting conditions which have clearly been disclosed. ESOPs are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the ESOPs are issued at significant discount to the market price. If the stock options are granted at a significant discount, there is no alignment between the interests of investors and those of employees.
    0 for1 against

Mutual fund votes, meeting of 9 Jan 2024, 34 fund houses

  • Appointment of Mr. Tarun Bajaj (DIN: 02026219) as an Independent Director of the Company
    34 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines and tax disputes

Reported in the filing for the quarter to Jun 2026.

  • Fine or penaltyAdjudicating Officer & Assistant Commissioner, MumbaiSince 18 Apr 2026

    A penalty of Rs. 90,000 was imposed jointly on Hindustan Unilever Limited (HUL/the Company), its Nominees and Distributor(s).

    The matter relates to a sample of Knorr Soupy Noodles collected for inspection in May 2015, which was found to be sub-standard under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, while the accompanying masala sachet was held to be misbranded under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. The Company has duly discharged the penalty imposedMoreLess
  • Fine or penaltyAdjudicating Officer & Assistant Commissioner, MumbaiSince 18 Apr 2026

    A penalty of Rs. 75,000 was jointly imposed on erstwhile GlaxoSmithKline Consumer Healthcare Limited (now merged with HUL), its Nominees and Distributor(s).

    This matter relates to a sample of Foodles Multigrain Ala Masala Noodles collected for inspection in June 2016, which was found to be sub-standard under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, while the accompanying masala sachet was found to be misbranded under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. HUL has duly discharged the penalty imposed in respect of this matter.MoreLess
  • Fine or penaltyAdjudicating Officer & Assistant Commissioner, MumbaiSince 18 Apr 2026

    A penalty of Rs. 50,000 was jointly imposed on HUL and its Nominees

    This matter relates to a sample of Mixed Fruit Jam collected for inspection in May 2016, which was found to be sub-standard under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. HUL has duly discharged the penalty imposed in respect of this matter.MoreLess
  • Fine or penaltyAdjudicating Officer & Assistant Commissioner, MumbaiSince 18 Apr 2026

    A penalty of Rs. 75,000 was jointly imposed on erstwhile GlaxoSmithKline Consumer Healthcare Limited (now merged with HUL), its Nominees and Distributor(s).

    This matter relates to a sample of Foodles Multigrain Ala Masala Noodles collected for inspection in June 2015, which was found to be sub-standard under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, while the accompanying masala sachet was found to be misbranded under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. The Company has duly discharged the penalty imposed in respect of this matter.MoreLess
  • Fine or penaltyAdjudicating Officer, ThaneSince 28 Apr 2026

    A penalty of Rs. 100,000 was jointly imposed on erstwhile GlaxoSmithKline Consumer Healthcare Limited (now merged with HUL), its Nominees and Distributor(s).

    This matter relates to a sample of Foodles Multigrain Ala Masala Noodles collected for inspection in June 2015, which was found to be sub-standard under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, while the accompanying masala sachet was found to be misbranded under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. The Company has duly discharged the penalty imposed in respect of this matter.MoreLess
  • Fine or penaltyAdjudicating Officer, ThaneSince 28 Apr 2026

    A penalty of Rs. 100,000 was jointly imposed on erstwhile GlaxoSmithKline Consumer Healthcare Limited (now merged with HUL), its Nominees and Distributor(s).

    This matter relates to a sample of Foodles Multigrain Ala Masala Noodles collected for inspection in June 2015, which was found to be sub-standard under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, while the accompanying masala sachet was found to be misbranded under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. The Company has duly discharged the penalty imposed in respect of this matter.MoreLess
  • Fine or penaltyAdjudicating Officer, ThaneSince 28 Apr 2026

    A penalty of Rs. 100,000 was imposed jointly on Hindustan Unilever Limited (HUL/the Company), its Nominees and Distributor(s).

    This matter relates to a sample of Knorr Soupy Noodles Mast Masala collected for inspection in June 2015, which was found to be sub-standard under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011, while the accompanying masala sachet was found to be misbranded under the Food Safety and Standards (Packaging and Labelling) Regulations, 2011. The Company has duly discharged the penalty imposed in respect of this matter.MoreLess
  • Tax disputeCommissioner of Income TaxSince 23 Aug 2024
    The Company represented its matter before CIT(A) on 17th April 2026. Thereafter, the Company received another notice for hearing scheduled on 16th June 2026, which was also heard. The next hearing date is awaited.MoreLess
    At the filing before: Vide our letter dated 26th August 2024, we had intimated about a Demand of INR 962.75 Crores raised on the Company on account of non-deduction of TDS as per the provisions of the Income Tax Act, 1961 while making remittance for payment towards acquisition of India HFD IPR from GlaxoSmithKline ‘GSK’ Group entities. The Company had thereafter periodically informed about filing an appeal before the Commissioner of Income Tax (Appeals), Mumbai [CIT(A)], against the Assessment Order and Demand, along with applications for stay of Demand and abeyance of penalty proceedings before the Assessing Officer. Pursuant to the Assessing Officer’s Order dated 6th November 2024, the Company was directed to pay 20 percent of the outstanding Income Tax Demand of INR 962.75 Crores and the balance demand was kept in abeyance. Accordingly, the Company paid INR 192.55 Crores on 28th November 2024. The payment was made out of proceeds received under an indemnification claim pursuant to the relevant Sale and Purchase Agreement and hence had no financial impact on the Company. In relation to the appeal before the CIT(A), the Company filed its submissions on 11th April 2025. The first hearing in the matter was held on 19th September 2025, during which the Company provided a brief background of the case. Further, he Company received a notice from CIT(A) dated 11th March 2026 for hearing scheduled on 17th April 2026.MoreLess
2 more
  • Tax disputeAssistant Commissioner of Income-Tax, Central Circle 5(2), MumbaiSince 30 Oct 2025
    The ITAT hearing is re-scheduled to 5th August 2026.
    At the filing before: Vide our letter dated 31st October 2025, we had intimated about the Assistant Commissioner's Order dated 30th October 2025, with respect to Notice of Demand of INR 1986.25 Crores under the Income Tax Act, 1961 (ITA) citing that the Tax authorities had made transfer pricing adjustments in the nature of disallowance of payments to related parties or challenged the valuation of such related party payments and corporate tax disallowances in the nature of depreciation claimed. During the quarter ended December 2025, the Company had obtained stay of Demand Order dated 26th November 2025, subject to payment of 20 percent of the total tax demand. Further, the Company had filed an appeal before the Hon'ble Mumbai Income-Tax Appellate Tribunal (ITAT) on 23rd December 2025. The ITAT hearing was scheduled on 28th April 2026.MoreLess
  • Tax disputeAssistant Commissioner of Income-Tax, Central Circle 5(2), MumbaiSince 7 Jan 2026
    The ITAT hearing is re-scheduled to 5th August 2026.
    At the filing before: Vide our letter dated 8th January 2026, we had intimated about the Assistant Commissioner's Order dated 7th January 2026 with respect to Notice of Demand of INR 1559.69 Crores under the ITA citing that the Tax authorities had made transfer pricing (disallowance of payments to related parties or challenged the valuation of such related party payments) and corporate tax adjustments (disallowances in the nature of depreciation claimed) similar to FY 2020-21 (AY 2021-22). The Company had obtained stay of Demand Order dated 2nd February 2026 subject to payment of 20 percent of the total tax demand. Further, the Company had filed an appeal before the ITAT on 27th March 2026.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 2 complaints open, quarter to Jun 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.